The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules
AbstractIn 1991 a most-favored-customer (MFC) rule was adopted to govern pharmaceutical prices paid by Medicaid. Theoretical models show that an MFC rule commits a firm to compete less aggressively in prices. I find that the price of branded products facing generic competition rose (4% on average). Brands protected by patents did not significantly increase in price. Generics in concentrated markets should display a strategic response to the brand's adoption of the MFC; I find that generic firms raise price more as their markets become concentrated. Hospital prices show little change. The results suggest that the MFC rule caused higher prices for some pharmaceutical customers.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by Yale School of Management in its series Yale School of Management Working Papers with number ysm58.
Date of creation: 25 Jun 1997
Date of revision:
Find related papers by JEL classification:
- L15 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - Information and Product Quality
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology
- L10 - Industrial Organization - - Market Structure, Firm Strategy, and Market Performance - - - General
You can help add them by filling out this form.
CitEc Project, subscribe to its RSS feed for this item.
- Kyle Margaret, 2011.
"Strategic Responses to Parallel Trade,"
The B.E. Journal of Economic Analysis & Policy,
De Gruyter, vol. 11(2), pages 1-34, January.
- Jonathan Gruber, 2000.
NBER Working Papers
7829, National Bureau of Economic Research, Inc.
- Kazuhiro Ohnishi, 2010. "Most-Favoured-Customer Pricing and Labour-Managed Oligopoly," Journal of Industry, Competition and Trade, Springer, vol. 10(1), pages 33-40, March.
- Martin Gaynor & William B. Vogt, 1999.
"Antitrust and Competition in Health Care Markets,"
NBER Working Papers
7112, National Bureau of Economic Research, Inc.
If references are entirely missing, you can add them using this form.